ENVERIC BIOSCIENCES INC (ENVB) Stock News
NASDAQ:ENVB - Nasdaq - US29405E4061 - Common Stock - Currency: USD
ENVB Latest News, Press Relases and Analysis
All
Press Releases
4 days ago - Enveric Biosciences
Enveric Biosciences Identifies Neuroplastogen Candidates with Potential to Address Neurodegenerative Disease
10 days ago - Enveric Biosciences
Enveric Biosciences Reports First Quarter 2025 Financial and Corporate Results
2 months ago - Enveric Biosciences
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2024
2 months ago - Enveric Biosciences, Inc.
Enveric Biosciences Participating in BIO-Europe Spring®
3 months ago - Enveric Biosciences
Enveric Biosciences Launches Request-For-Proposals Solicitation Process for PsyAI Trademark
3 months ago - Enveric Biosciences
Enveric Biosciences CEO Issues Letter to Shareholders
3 months ago - Enveric Biosciences
Enveric Biosciences Unveils EVM401 Series of Compounds with New U.S. Patent
4 months ago - Enveric Biosciences
Enveric Biosciences and Restoration Biologics Announce Licensing Agreements to Treat Joint Disease
4 months ago - Enveric Biosciences, Inc.
Enveric Biosciences Announces Closing of $5 Million Public Offering
4 months ago - Enveric Biosciences, Inc.
Enveric Biosciences Announces Pricing of $5 Million Public Offering
4 months ago - Enveric Biosciences